Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Ltd has informed the stock exchanges that its Board of Directors, at a meeting held on 7th June 2025, approved the appointment of Ms. Nikita Jain as the new Company Secretary and Compliance Officer of the company with effect from 7th June 2025. Ms. Nikita Jain is an Associate Member of the Institute of Company Secretaries of India (Membership No: A25156) and brings experience in FEMA compliance, corporate legal matters, SEBI/NSE compliances, secretarial audits, and regulatory governance. The disclosure has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine key managerial personnel change with no direct impact on the company's financials or operations. It is a governance update confirming that the company has a qualified Compliance Officer in place.